ReviewPLoS medicine2006
The latest mania: selling bipolar disorder.
Review in PLoS medicine, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed.
- Hamlet's augury: how to manage discontinuation of mood stabilizers in bipolar disorder.Therapeutic advances in psychopharmacology · 2021Review
- Polypharmacy-induced cognitive dysfunction and discontinuation of psychotropic medication: a neuropsychological case report.Therapeutic advances in psychopharmacology · 2020Article
- Bipolar II Disorder Is a Myth.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2019Article
- Antipsychotics use: 2006-2013 trends in prevalence and incidence and characterization of users.European journal of clinical pharmacology · 2018Article
- Article
- Towards a genealogy of pharmacological practice.Medicine, health care, and philosophy · 2016Article
- A neurobiological hypothesis of treatment-resistant depression - mechanisms for selective serotonin reuptake inhibitor non-efficacy.Frontiers in behavioral neuroscience · 2014Review
- Overdiagnosis of bipolar disorder: a critical analysis of the literature.TheScientificWorldJournal · 2013Review
- The dominance of big pharma: power.Medicine, health care, and philosophy · 2013Article
- Bipolar disorder and socioeconomic status: what is the nature of this relationship?International journal of bipolar disorders · 2013Article
- Generalizability of evidence-based assessment recommendations for pediatric bipolar disorder.Psychological assessment · 2012Article
- The increasing frequency of mania and bipolar disorder: causes and potential negative impacts.The Journal of nervous and mental disease · 2012Review
- Pediatric bipolar disorder in an era of "mindless psychiatry".Journal of trauma & dissociation : the official journal of the International Society for the Study of Dissociation (ISSD) · 2012Review
- Aripiprazole in the maintenance treatment of bipolar disorder: a critical review of the evidence and its dissemination into the scientific literature.PLoS medicine · 2011Review
- The bipolar spectrum: myth or reality?Current psychiatry reports · 2010Review
- A nearly overlooked mild case of ziprasidone-induced lingual dystonia.Journal of clinical psychopharmacology · 2010Article
- Controversies concerning the diagnosis and treatment of bipolar disorder in children.Child and adolescent psychiatry and mental health · 2010Article
- Getting to yes: corporate power and the creation of a psychopharmaceutical blockbuster.Culture, medicine and psychiatry · 2009Article
- The assessment of children and adolescents with bipolar disorder.Child and adolescent psychiatric clinics of North America · 2009Review
- Antidepressant-coincident mania in children and adolescents treated with selective serotonin reuptake inhibitors.Future neurology · 2009Article
Corrections and comments
- Commented on by
- Commented on by
- Erratum issued
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.